Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01632540 · ClinicalTrials.gov registry record
Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis
A clinical trial, sponsored by Teva Branded Pharmaceutical Products R&D.
- Completed
- Registry status
- 824
- Enrollment target
NCT01632540: Completed study, sponsored by Teva Branded Pharmaceutical Products R&D.
NCT01632540 is a clinical trial that has completed, run by Teva Branded Pharmaceutical Products R&D. The registered enrollment target is 824 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01632540 has completed, sponsored by Teva Branded Pharmaceutical Products R&D.
- COMPLETED
- Registry status
- 824 participants
- Enrollment target
Study Summary
This study will be a prospective observational study of "real world" BDP nasal aerosol users with PAR, with or without seasonal allergic rhinitis (SAR). Subjects will respond to monthly online surveys regarding rhinitis control, concomitant medical conditions, concomitant (non-AR) medications, current AR therapy, and adverse events.
Primary Outcome
The RCAT will be completed each month and uses a one-week recall period. This questionnaire has six items that ask about nasal and other allergy symptoms and the control of these symptoms. Each question is responded to on a scale of 1-5. The responses are summed to evaluate a total score. A higher score (22-30) indicates that symptoms are well controlled. A lower score (5-21) indicates that rhinitis symptoms are not well controlled.
Interventions
- DRUG Beclomethasone Dipropionate (BDP) Nasal Aerosol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 824 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-02 |
What the finished NCT01632540 record still lists
NCT01632540 is an observational study that tracks outcomes without assigning an intervention. The registered 824 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Beclomethasone Dipropionate (BDP) Nasal Aerosol is the first listed.
NCT01632540 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01632540 about?
NCT01632540 is a clinical study titled "Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis". This study will be a prospective observational study of "real world" BDP nasal aerosol users with PAR, with or without seasonal allergic rhinitis (SAR). Subjects will respond to monthly online surveys regarding rhinitis control, concomitant medical conditions, concomitant (non-AR) medications, curre...
What is the current status of trial NCT01632540?
This trial is currently completed. The enrollment target is 824 participants. The study started on 2012-07. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01632540?
The interventions under investigation include: Beclomethasone Dipropionate (BDP) Nasal Aerosol (DRUG).
Who is sponsoring clinical trial NCT01632540?
This trial is sponsored by Teva Branded Pharmaceutical Products R&D, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06944509 · 824 participants · NA
RADIQAL Study (Radiation Dose and Image Quality Trial)
- NCT05630482 · 825 participants · NA
Randomized Trial of Healthy Family Foundations
- NCT06097728 · 825 participants · Phase 3
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
- NCT07102641 · 825 participants · Phase 4
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia